InvestorsHub Logo

DaubersUP

10/24/17 8:55 AM

#201059 RE: keltoi #201052

It's good he sticks that in there. Subtle but good to hear. Great info today and good to hear they requested a meeting with the FDA.

Even better to go Oral for crohns and UC. The value there is unmatched.

I'm sure the optimized gel or foam is underway too for UP


Great news.

scottsmith

10/24/17 9:11 AM

#201070 RE: keltoi #201052

Numerous must mean at least five. If OM results are stellar, as we all expect, Uncle Leo will have ZERO excuses for not returning a mega deal for Brilacidin. With "numerous" pharmaceuticals interested in Brilacidin, good results (which is what we've seen thus far) should result in competition for the right to Brilacidin. If Leo can't ink a major deal for B during q1 2018 it will mean we shareholders have overestimated the results to date.

This PR has given Leo no room to hide pending good OM results. In that sense, I actually love this PR. Leo is now accountable to True Longs.